Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients

Yildiz, 2013, Evaluation of association between atherogenic index of plasma and intima-media thickness of the carotid artery for subclinic atherosclerosis in patients on maintenance hemodialysis, Hemodial Int, 17, 397, 10.1111/hdi.12041 García-López, 2007, Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis, Perit Dial Int, 27, S205, 10.1177/089686080702702s35 Vázquez, 2014, Sudden death in incident dialysis patients, Am J Nephrol, 39, 331, 10.1159/000360547 Zhe, 2008, Pulse Wave Velocity Is Associated with Metabolic Syndrome Components in CAPD Patients, Am J Nephrol, 28, 641, 10.1159/000117813 Bakris, 2012, Lipid disorders in uremia and dialysis, Contrib Nephrol, 178, 100, 10.1159/000337821 Prasad, 2013, Effect of metabolic syndrome on clinical outcomes of non-diabetic peritoneal dialysis patients in India, Nephrol (Carlton), 18, 657 Holmes, 2007, Glucotoxicity in Peritoneal Dialysis-Solutions for the Solution!, Adv Chronic Kidney Dis, 14, 269, 10.1053/j.ackd.2007.03.009 Li, 2013, Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis, Perit Dial Int, 33, 411, 10.3747/pdi.2012.00037 Schwenger, 2014, Dialysis and ultrafiltration therapy in patients with cardio-renal syndrome: recommendations of the working group “heart-kidney” of the German Cardiac Society and the German Society of Nephrology, Dtsch Med Wochenschr, 139, e1 Wang, 2011, Consequences of Chronic Inflammation in Peritoneal Dialysis, Semin Nephrol, 31, 159, 10.1016/j.semnephrol.2011.01.005 Quinn, 2011, Selection bias explains apparent differential mortality between dialysis modalities, J Am Soc Nephrol, 22, 1534, 10.1681/ASN.2010121232 Maoujoud, 2010, Prevalence of metabolic syndrome in chronic haemodialysis patients in Morocco, East Mediterr Health J, 16, 375 Li, 2009, Treatment of metabolic syndrome in peritoneal dialysis patients, Perit Dial Int, 29, S149, 10.1177/089686080902902S29 McIntyre, 2010, Tissue-advanced glycation end product concentration in dialysis patients, Clin J Am Soc Nephrol, 5, 51, 10.2215/CJN.05350709 Huang, 2013, Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients, Cardiovasc Diabetol, 12, 86, 10.1186/1475-2840-12-86 Jovanovic, 2008, Cardiovascular morbidity and mortality risk factors in peritoneal dialysis patients, Srp Arh Celok Lek, 136, 313, 10.2298/SARH0806313J Tbahriti, 2013, Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines, World J Nephrol, 2, 31, 10.5527/wjn.v2.i2.31 Tekin, 2008, Positive Correlation of CRP and Fibrinogen Levels as Cardiovascular Risk Factors in Early Stage of Continuous Ambulatory Peritoneal Dialysis Patients, Ren Fail, 30, 219, 10.1080/08860220701813350 Martins, 2007, Insulin Resistance Is Associated With Circulating Fibrinogen Levels in Nondiabetic Patients Receiving Peritoneal Dialysis, J Ren Nutr, 17, 132, 10.1053/j.jrn.2006.07.004 Wu, 2012, Role of homocysteine in end-stage renal disease, Clinical Biochemistry, 45, 1286, 10.1016/j.clinbiochem.2012.05.031 Ertek, 2010, The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients, Int Urol Nephrol, 42, 211, 10.1007/s11255-009-9625-y